Elanco Animal Health (ELAN) Earnings Date and Reports 2024 (2024)

Earnings Summary

Upcoming
Earnings Date
May. 14Estimated

Actual EPS
(Feb. 26)
$0.08 Missed By -$0.02

Consensus EPS
(Feb. 26)
$0.10

Get Elanco Animal Health Earnings Alerts

Enter your email address below to receive the latest news and earnings results for ELAN and its competitors with MarketBeat's FREE daily newsletter.

Earnings Per ShareRevenue

ELAN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ELAN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ad Crypto 101 MediaSHOCKING Altcoin Moves…Bitcoin's recent price boom has sent select altcoins into an absolute FRENZY!Which is why we've gathered 27 crypto experts to share their top picks and predictions as we rapidly approach the Bitcoin halving event this month…Click here to register now

Elanco Animal Health Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20241$0.26$0.26$0.260.250 - 0.280
Q2 20241$0.23$0.23$0.23
Q3 20241$0.20$0.20$0.20
Q4 20241$0.19$0.19$0.19
FY 20244$0.88$0.88$0.88
Q1 20251$0.32$0.32$0.32
Q2 20251$0.29$0.29$0.29
Q3 20251$0.23$0.23$0.23
Q4 20251$0.22$0.22$0.22
FY 20254$1.06$1.06$1.06

ELAN Earnings Date and Information

Elanco Animal Health last released its earnings results on February 26th, 2024. The reported $0.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.10 by $0.02. The company earned $1.04 billion during the quarter, compared to the consensus estimate of $1 billion. Its revenue for the quarter was up 5.1% compared to the same quarter last year. Elanco Animal Health has generated ($2.50) earnings per share over the last year (($2.50) diluted earnings per share). Earnings for Elanco Animal Health are expected to grow by 15.38% in the coming year, from $0.91 to $1.05 per share. Elanco Animal Health has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 14th, 2024 based off prior year's report dates.

Read More

Elanco Animal Health Earnings History by Quarter

Export to Excel

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/14/2024
Estimated)
-------
2/26/2024Q4 2023$0.10$0.08($0.02)$0.45$1.00 billion$1.04 billion
11/7/2023Q3 2023$0.12$0.18+$0.06$2.58$1.04 billion$1.07 billion
8/7/2023Q2 2023$0.05$0.18+$0.13$0.56$1.04 billion$1.06 billion
5/9/2023Q1 2023$0.29$0.45+$0.16$0.69$1.18 billion$1.26 billion
2/21/2023Q4 2022$0.13$0.19+$0.06$0.49$980.94 million$988.00 million
11/8/2022Q3 2022$0.16$0.20+$0.04$0.50$1.03 billion$1.03 billion

Elanco Animal Health (ELAN) Earnings Date and Reports 2024 (3)

Get the Latest News and Ratings for ELAN and Related Stocks

Enter your email address below to receive the latest news and analysts' ratings for Elanco Animal Health and its competitors with MarketBeat's FREE daily newsletter.

8/8/2022Q2 2022$0.26$0.36+$0.10$0.76$1.18 billion$1.18 billion
5/9/2022Q1 2022$0.35$0.36+$0.01$0.62$1.22 billion$1.23 billion
2/24/2022Q4 2021$0.17$0.21+$0.04$0.62$1.10 billion$1.11 billion
11/5/2021Q3 2021$0.17$0.19+$0.02$0.59$1.08 billion$1.13 billion
8/8/2021Q2 2021$0.26$0.28+$0.02$0.99$1.24 billion$1.28 billion
5/6/2021Q1 2021$0.23$0.37+$0.14$0.86$1.16 billion$1.24 billion

Elanco Animal Health Earnings - Frequently Asked Questions

When is Elanco Animal Health's earnings date?

Elanco Animal Health has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 14th, 2024 based off last year's report dates. Learn more on ELAN's earnings history.

Did Elanco Animal Health beat their earnings estimates last quarter?

In the previous quarter, Elanco Animal Health (NYSE:ELAN) missed the analysts' consensus estimate of $0.10 by $0.02 with a reported earnings per share (EPS) of $0.08. Learn more on analysts' earnings estimate vs. ELAN's actual earnings.

How can I listen to Elanco Animal Health's earnings conference call?

The conference call for Elanco Animal Health's latest earnings report can be listened to online. Listen to Conference Call

How can I read Elanco Animal Health's conference call transcript?

The conference call transcript for Elanco Animal Health's latest earnings report can be read online. Read Transcript

How can I view Elanco Animal Health's earnings report?

Elanco Animal Health's earnings report can be found in their filing with the SEC. View SEC filing

How much revenue does Elanco Animal Health generate each year?

Elanco Animal Health (NYSE:ELAN) has a recorded annual revenue of $4.42 billion.

How much profit does Elanco Animal Health generate each year?

Elanco Animal Health (NYSE:ELAN) has a recorded net income of -$1.23 billion. ELAN has generated -$2.50 earnings per share over the last four quarters.

What is Elanco Animal Health's price-to-earnings ratio?

Elanco Animal Health (NYSE:ELAN) has a forward price-to-earnings ratio of 16.20. The price/earnings-to-growth ratio is 1.62.

What is Elanco Animal Health's EPS forecast for next year?

Elanco Animal Health's earnings are expected to grow from $0.91 per share to $1.05 per share in the next year, which is a 15.38% increase.


More Earnings Resources from MarketBeat

Related Companies:

  • CERE Earnings Date
  • VKTX Earnings Date
  • JAZZ Earnings Date
  • CYTK Earnings Date
  • APLS Earnings Date
  • ROIV Earnings Date
  • ITCI Earnings Date
  • IONS Earnings Date
  • LEGN Earnings Date
  • BPMC Earnings Date

Earnings Tools:

  • Today's Earnings
  • Tomorrow's Earnings
  • Next Week's Earnings
  • Upcoming Earnings Calls
  • Earnings Newsletter
  • Earnings Call Transcripts
  • Corporate Guidance
  • Earnings Screener

Earnings By Country:

  • U.S. Earnings Reports
  • Canadian Earnings Reports
  • U.K. Earnings Reports
  • Australia Earnings Reports

Latest Articles:

  • What to Expect From the Q1 Earnings Reporting Season
  • Lululemon Stock Implodes Post Earnings, Guidance Muted
  • Applied Optoelectronics earnings dumper, pain now for gain later?
  • Is Roku worth a second look after the earnings panic selloff?
  • Dell Technologies breaks out ahead of earnings release
  • Novavax’s dispute resolution and upcoming earnings call
  • Impinj stock surges on strong earnings and guidance
Elanco Animal Health (ELAN) Earnings Date and Reports 2024 (2024)

FAQs

What is the target price for Elanco stock? ›

What are analysts forecasts for Elanco Animal Health stock? The 32 analysts offering price forecasts for Elanco Animal Health have a median target of 18.06, with a high estimate of 37.00 and a low estimate of 9.00.

Is Elanco profitable? ›

According to the 10 industry analysts covering Elanco Animal Health, the consensus is that breakeven is near. They anticipate the company to incur a final loss in 2024, before generating positive profits of US$83m in 2025. So, the company is predicted to breakeven just over a year from today.

What is the net worth of Elanco Animal Health? ›

Elanco Animal Health has a market cap or net worth of $7.27 billion as of April 11, 2024. Its market cap has increased by 59.92% in one year.

Is Elanco still owned by Eli Lilly? ›

Until 2019, the company was a subsidiary of Eli Lilly and Company, before being divested. It is the third-largest animal health company in the world. Greenfield, Indiana, U.S.

Is Elan a good stock to buy? ›

Out of 6 analysts, 4 (66.67%) are recommending ELAN as a Strong Buy, 0 (0%) are recommending ELAN as a Buy, 1 (16.67%) are recommending ELAN as a Hold, 0 (0%) are recommending ELAN as a Sell, and 1 (16.67%) are recommending ELAN as a Strong Sell.

Should I buy Elanco stock? ›

Elanco Animal Health Incorporated - Hold

Its Value Score of B indicates it would be a good pick for value investors. The financial health and growth prospects of ELAN, demonstrate its potential to outperform the market. It currently has a Growth Score of C.

Why is Elanco stock so low? ›

As we suspected, our examination of Elanco Animal Health's analyst forecasts revealed that its inferior revenue outlook is contributing to its low P/S. Right now shareholders are accepting the low P/S as they concede future revenue probably won't provide any pleasant surprises.

Did Elanco buy Bayer Animal Health? ›

One of the most significant changes Elanco announced was its acquisition of Bayer Animal Health in 2019.

What was the old name of Elanco? ›

The Elanco brand, short for Eli Lilly and Company, came to be in 1960, following the reorganization of Eli Lilly and Company's Agricultural and Industrial Sales Division.

What is Elanco Animal Health ranked? ›

Elanco Animal Health was ranked in 100th position in Top 100 health & pharmaceutical companies.

How many employees does Elanco Animal Health have? ›

Elanco Animal Health had 9,800 employees on December 31, 2023. The number of employees increased by 60 or 0.62% compared to the previous year.

Is Elanco a Fortune 500 Company? ›

Elanco is a division of Eli Lilly and Company, a Fortune 500 global pharmaceutical corporation in Indianapolis with a heritage more than 130 years strong.

When did Elanco buy Bayer Animal Health? ›

Leverkusen, August 3, 2020 - Bayer has completed the sale of its Animal Health business unit to U.S. company Elanco Animal Health Incorporated. The companies had signed an agreement to this effect in August of last year.

When did Lilly sell Elanco? ›

Eli Lilly and Co. completed its separation from Elanco Animal Health Inc. after completing an exchange offer to divest its 80.2% stake in the animal health business. Indianapolis-based Eli Lilly spun off the animal health unit in 2018 through a $1.7 billion NYSE IPO.

Who is the competitor of Elanco? ›

Elanco main competitors are Warner Chilcott, Merck, and U.S. Pharmacopeia. Competitor Summary. See how Elanco compares to its main competitors: Roche Holding AG has the most employees (94,442).

Is Elanco a buy or sell? ›

Elanco Animal Health's analyst rating consensus is a Moderate Buy. This is based on the ratings of 6 Wall Streets Analysts. Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

What is the stock price prediction for BioCryst Pharmaceuticals? ›

BCRX Stock 12 Months Forecast

Based on 7 Wall Street analysts offering 12 month price targets for BioCryst in the last 3 months. The average price target is $14.71 with a high forecast of $30.00 and a low forecast of $6.00. The average price target represents a 219.78% change from the last price of $4.60.

Does Elanco pay a dividend? ›

Elanco Animal Health (NYSE: ELAN) does not pay a dividend.

What is the target price for Rex stock? ›

REX (REX) Price Targets
Average Price TargetHighest Price TargetDownside to Average Price Target
$58.00$58.00-2.73%

References

Top Articles
Latest Posts
Article information

Author: Greg Kuvalis

Last Updated:

Views: 6740

Rating: 4.4 / 5 (75 voted)

Reviews: 90% of readers found this page helpful

Author information

Name: Greg Kuvalis

Birthday: 1996-12-20

Address: 53157 Trantow Inlet, Townemouth, FL 92564-0267

Phone: +68218650356656

Job: IT Representative

Hobby: Knitting, Amateur radio, Skiing, Running, Mountain biking, Slacklining, Electronics

Introduction: My name is Greg Kuvalis, I am a witty, spotless, beautiful, charming, delightful, thankful, beautiful person who loves writing and wants to share my knowledge and understanding with you.